Mulmit

ImageneBio, Inc.ImageneBio, Inc.

IMA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31800,000-48,451,000-45,349,000-9.64
2024-12-313,500,000-37,000,000-36,568,000-22.1
2023-12-319,160,000-75,417,000-68,166,000-1.63
2022-12-3115,618,000-70,904,000-68,765,000-1.9
2021-12-3130,985,000-34,138,000-34,115,000-1.22

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-14Grant-Huerta YaninaChief Financial Officer65,000
2026-08-14Grant-Huerta YaninaChief Financial Officer39,000
2026-08-14Grant-Huerta YaninaChief Financial Officer56,000
2026-08-14Yarema KristinChief Executive Officer254,800
2026-08-14Yarema KristinChief Executive Officer137,200
2026-08-14Yarema KristinChief Executive Officer250,000
2026-07-25Yarema KristinChief Executive Officer38,376
2026-07-25Yarema KristinChief Executive Officer115,129
2026-07-25Yarema KristinChief Executive Officer38,376
2026-07-25Yarema KristinChief Executive Officer115,129
2026-07-17Lally Robert BPrincipal Accounting Officer1,525
2026-07-16Lally Robert BPrincipal Accounting Officer1,671

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-07-23Officer or director change · Other events · Financial statements and exhibits
2026-06-26Officer or director change
2026-06-17Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-07Results of operations · Financial statements and exhibits
2026-04-13Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-03-17Officer or director change
2026-03-10Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.